Boxer Capital, Llc Pandion Therapeutics, Inc. (PAND) insider trading activity

Boxer Capital, LLC is > 10% Shareholder of Pandion Therapeutics, Inc.. Currently has a direct ownership of 2.11 Million shares of PAND, which is worth approximately $126 Million. The most recent transaction as insider was on Jul 21, 2020, when has been sold 1,385,291 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.11M

0% 3M change

0% 12M change

Total Value Held $126 Million

Boxer Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 21 2020	BUY Conversion of derivative security	-	1,385,291 Added 50.0%	1,385,291 Common Stock
Jul 21 2020	BUY Open market or private purchase	$12,999,996 $18.0 p/Share	722,222 Added 25.52%	2,107,513 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

ODTC

Odonate Therapeutics, Inc. Financial Services

> 10% Shareholder

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

SLDB

Solid Biosciences Inc. Healthcare

> 10% Shareholder

ITOS

iTeos Therapeutics, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

RAIN

Rain Therapeutics Inc. Healthcare

TYRA

Tyra Biosciences, Inc. Healthcare

TNGX

Tango Therapeutics, Inc. Healthcare

BCL